Showing results (61-70 of 77) with videos related to
Sort By:
Pageof 8
European Journal of Pharmacology|February 9, 1988
Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2'Me-MPTPM V Kindt, S K Youngster, P K Sonsalla, et al.Neurology|July 1, 1992
Levodopa-nonresponsive Lewy body parkinsonism: clinicopathologic study of two casesM H Mark, J I Sage, D W Dickson, et al.Neurology|November 1, 1984
Pathology of olivopontocerebellar atrophy with glutamate dehydrogenase deficiencyS Chokroverty, R Khedekar, B Derby, et al.European Journal of Pharmacology|March 18, 1986
1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-CH3-MPTP) is a more potent dopaminergic neurotoxin than MPTP in miceS K Youngster, R C Duvoisin, A Hess, et al.Neurology|July 1, 1983
Parkinson's disease in 65 pairs of twins and in a set of quadrupletsC D Ward, R C Duvoisin, S E Ince, et al.Neurology|November 1, 1993
Autosomal dominant parkinsonism with benign course and typical Lewy-body pathologyL I Golbe, A M Lazzarini, K O Schwarz, et al.Annals of Neurology|November 1, 1996
Clinical genetic analysis of Parkinson's disease in the Contursi kindredL I Golbe, G Di Iorio, G Sanges, et al.Neurology|August 1, 1994
Meige syndrome in the spectrum of Lewy body diseaseM H Mark, J I Sage, D W Dickson, et al.Clinical Neuropharmacology|June 1, 1988
Isolated jejunal pouches for levodopa delivery in parkinsonian patients with "on-off". Successful experimental model in dogsJ I Sage, S Trooskin, L Schuh, et al.Neurology|December 1, 1988
Supranuclear disturbances of ocular motility in Lytico-BodigF E Lepore, J C Steele, T A Cox, et al.Pageof 8